WO2003020362A2 - Automated external defibrillator (aed) system - Google Patents
Automated external defibrillator (aed) system Download PDFInfo
- Publication number
- WO2003020362A2 WO2003020362A2 PCT/US2002/027817 US0227817W WO03020362A2 WO 2003020362 A2 WO2003020362 A2 WO 2003020362A2 US 0227817 W US0227817 W US 0227817W WO 03020362 A2 WO03020362 A2 WO 03020362A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- defibrillator
- patient
- pulse
- shock pulse
- impedance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3904—External heart defibrillators [EHD]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/046—Specially adapted for shock therapy, e.g. defibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3906—Heart defibrillators characterised by the form of the shockwave
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3925—Monitoring; Protecting
- A61N1/3937—Monitoring output parameters
- A61N1/3943—Monitoring output parameters for threshold determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3968—Constructional arrangements, e.g. casings
Definitions
- This invention relates to defibrillators in general, and more particularly to automated external defibrillators (AED's). Background Of The Invention
- the heart pumps blood through the body using coordinated heart muscle contractions.
- Ventricular fibrillation is a chaotic heart rhythm that causes an uncoordinated quivering of the heart muscle.
- the lack of coordinated heart muscle contractions results in the loss of blood flow to the brain and other organs. This is sometimes referred to as cardiac arrest.
- cardiopulmonary resuscitation can sustain a patient in cardiac arrest for a short time, only defibrillation can restore a normal heart rhythm. Without defibrillation, the victim will die.
- ventricular tachycardia can also cause cardiac arrest. More particularly, ventricular tachycardia is a very rapid heart rhythm which can also cause a loss of blood flow. Like ventricular fibrillation, the only effective treatment for pulseless ventricular tachycardia is defibrillation. Defibrillators are commonly used to treat ventricular fibrillation and ventricular tachycardia. Defibrillators are electronic devices that apply an electric pulse to stop the chaotic fibrillation of the heart and restore the normal heart rhythm. There are a variety of different types of defibrillators, but most can be classified into two categories: internal (sometimes referred to as implanted) defibrillators and external defibrillators.
- Internal (or implanted) defibrillators are provided for people whose heart is at considerable risk of fibrillation at some point in the near future. Therefore, physicians predict the need for electro-therapy in a patient and implant, via surgery, a defibrillator.
- a mechanism is provided in the implanted defibrillator for monitoring heart rhythms and, when the detected rhythm suggests fibrillation, the implanted defibrillator generates an electric pulse that stops fibrillation and restores the normal heart rhythm.
- One major advantage of internal defibrillators is that they can be customized for each and every patient, taking into account a variety of different parameters associated with that specific patient.
- External defibrillators are applied externally to the patient. These defibrillators are typically used in hospitals, emergency rooms, offices, airplanes, etc./ where electro-therapy might be required on short notice. In such places, there is a need for a defibrillator (such as an external defibrillator) that can be applied quickly and work dynamically with the varying parameters associated with different patients. External defibrillators provide these features, able to be applied quickly in an emergency situation and working effectively with many different patients so as to stop fibrillation and restore the normal heart rhythm. As noted above, external defibrillators are applied externally to the patient and deliver an electric pulse that propagates to the heart. In other words, the pulse generated by the defibrillator passes through the skin of the patient, travels through the tissue of the thorax and finally reaches the heart.
- the generated pulse needs to have considerable voltage in order to overcome the impedance associated with the intervening tissue.
- the pulse must have sufficient current to achieve the therapeutic effect. This need for considerable energy (high voltage and sufficient current) generally complicates hardware design and typically makes prior art external defibrillator systems large, heavy and expensive.
- Another problem associated with external defibrillators is the difficulty in providing an appropriate electric pulse to the heart. More particularly, as noted above, in external defibrillators, the defibrillator pulse must overcome the impedance of the tissue lying between the defibrillator and the heart. However, it has been found that the impedance of the intervening tissue varies significantly from patient to patient. Thus, a measurement should be made to determine the specific impedance associated with each particular patient. The amount of shock or pulse voltage needed for effective defibrillation is directly related to this measured impedance: the greater the impedance, the greater the voltage that is required in order to overcome the impedance associated with the tissue.
- AED's Automated external defibrillators
- AED's are also known in the prior art. AED's are designed to automatically analyze the victim' s heart rhythm and, if it is found to be in fibrillation, deliver an appropriate electric pulse (or "shock") to the heart so as to restore the normal heart rhythm.
- AED's can be successfully used in a wider range of locations (e.g., airplanes) by a wider range of first-responder personnel (e.g., flight attendants) , thereby significantly reducing the response time for patients in cardiac arrest and thus significantly increasing their chance for survival.
- first-responder personnel e.g., flight attendants
- survival rates drop by approximately 7-10% with every minute that passes after that. In essence, after approximately 10 minutes, there is relatively little chance for survival.
- the present invention provides a novel automated external defibrillator (AED) system that comprises an automated external defibrillator (AED) and a pair of associated electrodes.
- AED automated external defibrillator
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator being adapted to: (1) measure the thoracic impedance of the patient; and (2) provide a bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by a tilt which is less than the time constant of a 100 ⁇ F capacitance; and (ii) having a peak current limited in accordance with the measured impedance of the patient.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator being adapted to: (1) measure the thoracic impedance of the patient; and (2) provide a bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by a tilt which is less than the time constant of a 100 ⁇ F capacitance; and (ii) having a shock voltage selected in accordance with the measured impedance of the patient, wherein the shock voltage is generated by apparatus charged to a fixed charge voltage.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator being adapted to: (1) measure the thoracic impedance of the patient; and (2) provide a bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by a tilt which is less than the time constant of a 100 ⁇ F capacitance; (ii) having a peak current limited in accordance with the measured impedance of the patient; and (iii) having a shock voltage selected in accordance with the measured impedance of the patient, wherein the shock voltage is generated by apparatus charged to a fixed charge voltage.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator being adapted to: (1) measure the thoracic impedance of the patient; and (2) provide a bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by a tilt which varies in accordance with the measured impedance of the patient; and (ii) being characterized by a tilt which is less than the time constant of a 100 ⁇ F capacitor.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator being adapted to: (1) measure the thoracic impedance of the patient; and (2) provide a bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by a tilt which is less than the time constant of a 100 ⁇ F capacitance; (ii) having a time duration selected in accordance with the measured impedance of the patient; and (iii) having a peak current limited in accordance with the measured impedance of the patient.
- a defibrillator for applying a therapeutic pulse to a patient, the defibrillator being adapted to:
- bi-phasic shock pulse to the patient, the bi-phasic shock pulse: (i) being characterized by an increased average current in accordance with the measured impedance of the patient.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator comprising: a body enclosing hardware for generating the shock pulse; and a lid for covering all of the user accessible components of the body.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator comprising: a body enclosing hardware for generating the shock pulse; and a lid for covering at least a portion of the body, the lid being adapted to releasably store an electrode tray on the underside of the lid.
- a package for storing electrodes prior to use with a defibrillator comprising: a substantially rigid tray defining a recess for receiving the electrodes; and a peel-off sheet releasably secured to the tray so as to hermetically seal the electrodes within the recess.
- an electrode for use in applying an electric current to a patient, the electrode comprising: a hydrogel pad having a first generally rectangular shape with rounded corners; and a conductor mounted to the hydrogel pad, the conductor having a second generally rectangular shape with rounded corners, with the footprint of the conductor being less that the footprint of the hydrogel pad, the conductor being configured at a first edge thereof to be connected to the circuit for applying the electric current to the patient, whereby when the conductor is mounted to the hydrogel pad, the hydrogel pad will overlap the conductor on at least the three remaining edges.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator having a footprint substantially the size of the footprint of its associated electrodes.
- a defibrillator for applying a therapeutic shock pulse to a patient, the defibrillator comprising: a body enclosing hardware for generating the shock pulse, the body including a communication device for accessing the hardware without opening the body.
- a defibrillator comprising a body that encloses hardware associated with the defibrillator, and further comprising a fault analysis system comprising a visual signal indicating whether or not there is a malfunction in the hardware, the visual signal being visible without opening the body.
- an electrode tray where electrodes in the tray are face-to-face on a release liner.
- an electrode connector that includes a component that allows a defibrillator to detect when the connector is inserted.
- electrodes in a package with an anode-to- cathode resistor which: (a) allow device impedance circuit testing in periodic self-tests; (b) identify a unique electrode for shelf life duration monitoring; and (c) the resistor can be removed or modified by the periodic self-tests by using the defibrillator pulse when shelf life has expired.
- the defibrillator waveform (a) Pre-pulse detects: have thoracic impedance, detects impedance to real defibrillation currents, determines selection of capacitors, and determines waveform duration; (b) Prepulse is used to determine the control of a waveform greater that 250 joules; (c) Capacitor selection allows delivery of a pulse into thoracic impedance from 25-200 ohms without a change in capacitor voltage; (d) Capacitor selection allows delivery of a pulse into thoracic impedance from 25-200 ohms without inserting series resistors.
- Defibrillation waveform electronics (a) Patient-connected leads have leakage protection with semiconductors, from the defibrillator capacitor high voltage; (b) Patient-connected leads are protected from a second external defibrillator (damped sine wave or multi-phasic) with semiconductors; (c) Patient- connected leads are protected from ESD discharge with semiconductors; (d) Double fault protection of the defibrillator high voltage to the patient leads is provided with semiconductors; and (e) ECG monitoring allows +/-5 volt offset voltages while connected to the defibrillation high voltage capacitors.
- defibrillator capacitor voltage is dumped with internal discharge electronics that utilize low power, low cost semiconductors.
- Battery for device operation is sized to perform a single patient rescue sequence and be replaced for the next patient rescue.
- capacitor charging with low voltage from battery combined with a safety dump circuit that stops dumping at a voltage just above the battery voltage.
- a connector for detecting the nature of an associated electrode and its current use there is provided a battery for use in a defibrillator, the battery being sized for a single rescue event.
- an automated external defibrillator comprising a key receptacle, with the defibrillator being configured for manual operation when the key receptacle is filled.
- a defibrillator comprising a safety circuit having a shock delivery switch providing redundant control to the therapy delivery circuits.
- a defibrillator having an independent time base, and alarm activation, for initiating periodic self-testing.
- a defibrillator adapted to provide continuous ECG analysis for detection of ventricular fibrillation during periods of operator contact with the patient for the purpose of expediting delivery of defibrillation shocks .
- a defibrillator adapted to provide real-time coaching to a user during a rescue.
- Fig. 1 is a schematic diagram illustrating how the novel automated external defibrillator (AED) system of the present invention addresses a significant market need
- Fig. 2 is a schematic diagram illustrating the novel AED system of the present invention applied to a patient
- Fig. 3 is a schematic diagram showing the distribution curve for thoracic impedance for a typical patient population
- Fig. 4 is a schematic diagram of a bi-phasic waveform useful in defibrillating the heart
- Fig. 5 is a schematic diagram of a bi-phasic waveform illustrating that the slope (or "tilt") of the waveform is a function of patient impedance and defibrillator capacitance;
- Fig. 6 is a schematic diagram showing how the slope (or "tilt") of a bi-phasic waveform flattens with increasing patient impedance;
- Fig. 7 is a schematic diagram showing how the slope (or "tilt") of a bi-phasic waveform flattens with increasing defibrillator capacitance;
- Fig. 8 is a schematic diagram showing the strength duration curve which illustrates the relationship between current, time and successful defibrillation
- Fig. 9 is a schematic diagram showing how the calculated average current level can be determined where the defibrillator has a sloping current curve (e.g., with a capacitance-generated pulse);
- Fig. 10 is a schematic diagram illustrating how it is possible to widen the width of the shocking pulse, and thereby change the calculated average current level, by allowing the capacitance to discharge longer;
- Fig. 11 is a schematic diagram illustrating how the gap between a 100 ⁇ F capacitance curve and the 50% successful defibrillation curve remains fairly constant regardless of how much the shock pulse is elongated;
- Fig. 12 is a schematic diagram illustrating how the gap between a 200 ⁇ F capacitance curve and the 50% successful defibrillation curve increases as the shock pulse is elongated;
- Fig. 13 is a schematic diagram illustrating one preferred technique for providing the bi-phasic waveform of the present invention.
- Fig. 14 is a schematic illustration of the bi-phasic waveform produced by the present invention.
- Fig. 15 is a perspective view of the novel AED system with its cover closed
- Fig. 16 is a perspective view of the novel AED system with its cover opened
- Fig. 17 is a view showing the front face of the system's defibrillator
- Fig. 18 is a view showing the defibrillator' s battery slot and flashcard slot
- Fig. 19 is a view showing the defibrillator' s battery
- Fig. 20 is a view showing the defibrillator' s speaker, microphone, alarm and selected internal electronics
- Fig. 21 is a view showing the rear side of the defibrillator' s front casing, showing the speaker ports, microphone ports and alarm ports;
- Fig. 22 is a schematic diagram of the defibrillator system
- Fig. 23 is another schematic diagram of the defibrillator system
- Fig. 24 is a schematic diagram of the defibrillator' s H-Bridge circuit
- Fig. 25 is a schematic diagram of the defibrillator' s internal energy dump circuit
- Fig. 26 is a view showing the system's electrode package, with the package's sheet of sealing material having been removed from the tray;
- Fig. 27 is a perspective view of one end of electrode package's tray, with the tray being shown at an intermediate stage of manufacture;
- Fig. 28 is a perspective view showing the same end of the tray, with the tray being shown at a subsequent stage of manufacture;
- Fig. 29 is a perspective view showing the other end of the tray.
- Fig. 30 is a perspective view showing one end of the underside of the system's cover
- Fig. 31 is a perspective view showing the other end of the underside of the system's cover
- Fig. 32 is a view showing various elements used to construct the system's electrodes;
- Fig. 33-38 show various steps in the construction of the system's electrodes;
- Fig. 39 is a perspective view showing one preferred way to connect the electrodes to the tray.
- Fig. 1 illustrates various clinical needs associated with cardiac fibrillation and the proposed solutions for those clinical needs. Delays in the detection of ventricular fibrillation, 5, may be averted by a broad deployment of low cost defibrillators, 10. Similarly, a delay in defibrillation therapy, 15, and the availability of a limited number of defibrillators, 20, can be avoided by providing for a broad deployment of low cost defibrillators, 10. The problems associated with the high cost of training to use a defibrillator, 25, thereby resulting in fewer trained personnel, is overcome by automated external defibrillators (AED's). All these needs and solutions, as well as others, are addressed by the novel defibrillator system 35 (Figs.
- a defibrillator is designed to deliver a therapeutic electric shock to the heart in order to stop chaotic fibrillation and restore the normal heart rhythm.
- an external defibrillator In order for successful defibrillation to be achieved, an external defibrillator must deliver sufficient voltage to overcome the thoracic impedance of the patient and sufficient current to provide the therapeutic effect to the heart muscle.
- the level of thoracic impedance tends to vary from person to person.
- the distribution of thoracic impedance generally follows a bell-shaped curve. More particularly, and looking now at Fig. 3, the distribution curve for thoracic impedance is typically centered at about 75 ohms, with about 90% of the population falling in the range of between about 25 ohms and about 120 ohms.
- Ohm's law if a defibrillating pulse of fixed voltage is applied to a patient, the level of current entering the patient will vary in accordance with the thoracic impedance of the patient.
- the current delivered to the patient may go too high, which can result in burning or other tissue damage, including cardiac stunning and reduced efficacy; alternatively, for high impedance patients, the current delivered to the patient may go too low and fail to provide the desired therapeutic benefit, i.e., the heart will not be successfully defibrillated.
- the voltage of the defibrillating pulse can be desirable to vary the voltage of the defibrillating pulse according to the impedance of the patient.
- the defibrillator In order for an external defibrillator to be used in the widest possible range of situations, the defibrillator should be portable. As a result, portable external defibrillators traditionally rely on batteries as their source of electrical energy. Since batteries are generally able to deliver only a limited voltage, most portable defibrillators use capacitors to accumulate charge from the battery and release it in the shocking pulse.
- the waveforms tend to have a slope (or "tilt") that is a function of (i) the patient's thoracic impedance, and (2) the defibrillator' s capacitance (Fig. 5). More particularly, and looking now at Fig. 6, for a fixed voltage defibrillator, an increase in thoracic impedance tends to reduce the tilt of the bi-phasic waveform. Similarly, and looking now at Fig. 7, for a fixed voltage defibrillator, an increase in capacitance tends to reduce the tilt of the bi-phasic waveform.
- lower capacitance e.g. 100 ⁇ F
- lower capacitance is generally lighter
- lower capacitance is typically cheaper
- lower capacitance requires less energy from the battery, thus allowing smaller and lighter batteries to be used in the defibrillator.
- a given fixed voltage defibrillator will provide a bi-phasic waveform having different tilt profiles depending on the impedance of the patient and on the capacitance of the defibrillator.
- the defibrillator can either apply a current of level Ai for a time ti, or it can apply a current of level A 2 for a time t 2 , where A > A 2 and t 2 > ti.
- the effective current level can be considered to be the calculated average current level. More particularly, with the capacitance-generated pulse shown in Fig. 9, the pulse is considered to have a calculated average current of level A A for time t F .
- the defibrillator uses a 100 ⁇ F capacitance to generate its shocking pulse, the defibrillator will have an effective current curve which looks something like that shown in Fig. 10, depending on how long the capacitance is allowed to discharge.
- defibrillator system 35 comprises a portable bi-phasic defibrillator having a higher (e.g., 200 ⁇ F) capacitance.
- a significantly more effective bi- phasic defibrillator can be constructed by configuring the defibrillator so that for higher impedance patients, it (1) has a higher capacitance (e.g., 200 ⁇ F) so that it has a reduced tilt to its waveform, whereby to obtain a higher calculated average current level for a similar shock voltage, and (2) has an elongated pulse width, whereby providing a higher defibrillation efficiency.
- a higher capacitance e.g. 200 ⁇ F
- the defibrillator is configured so as to limit the current and thereby reduce cardiac stunning and post shock arrhythmias. This is preferably done by controlling the shape of the defibrillation pulse, by applying a lower voltage with a larger effective capacitance. Furthermore, it has been discovered that a bi-phasic waveform having a phase 2:phase 1 charge ratio of approximately 0.38 is most efficacious. In this respect it should be appreciated that in the context of Fig. 4, the charge ratio can be thought of as the ratio of the bordered area of phase 2 divided by the bordered area of phase 1.
- the applied voltage and the higher (e.g., 200 ⁇ F) effective capacitance is provided by a bank of individual capacitors, at least some of which are stacked 2 high, all charged to a common voltage and switchable so as to configure a desired discharge.
- a bank of individual capacitors at least some of which are stacked 2 high, all charged to a common voltage and switchable so as to configure a desired discharge.
- S2 and S3 anywhere from 2-6 capacitors may be fired, so as to provide a voltage of 660-1980 volts.
- the capacitor circuit shown in Fig. 13 comprises six 1200 ⁇ F capacitors which, depending on the state of switches SI, S2 and S3, can be configured to provide a range of voltages with differing capacitances.
- the following table shows some of the possible configurations for the capacitor circuit :
- the capacitor circuit shown in Fig. 13 comprises 6 1200 ⁇ F capacitors, all charged to a fixed charge voltage of 330 volts, and depending on the state of its three switches SI, S2 and S3, is capable of providing anywhere from 660 to 1980 volts, at a capacitance of anywhere from 1800 ⁇ F to 200 ⁇ F. Significantly, a minimum of 200 ⁇ F is maintained even when all 6 capacitors are fired.
- the defibrillator is configured to initially discharge, very briefly, 1 set of 2 stacked capacitors so as to generate a "pre-pulse".
- This pre-pulse has a duration long enough to obtain an accurate reading of the patient's thoracic impedance due to electrode-to-skin interface effects, but short enough to avoid substantially depleting the capacitors.
- the pre-pulse is terminated prior to applying the subsequent therapeutic pulse (see below) .
- the pre-pulse is approximately 100 ⁇ seconds to 1 millisecond in duration to resolve the correct prediction of patient impedance.
- the level of current of the pre-pulse will vary in accordance with the thoracic impedance of the patient.
- the pre-pulse current level must be sufficient to predict patient impedance.
- the unit is ready to apply the therapeutic shock to the patient. More particularly, once the defibrillator has identified the thoracic impedance of patient, it can determine how much voltage to apply to that patient in order to provide the appropriate therapeutic shock, the duration of the pulse and the desired shape of the pulse. The defibrillator then determines how many of the capacitors to fire in order to achieve the desired shock voltage (and hence the desired shock current) , and then fires that number of capacitors for the desired pulse width. By choosing exactly how many capacitors are fired, the level of voltage applied to the patient can be regulated, and thus the level of current applied to the patient can be regulated. As a result, the defibrillator can avoid applying too much current to patients having a low thoracic impedance while still ensuring that an effective shocking pulse is delivered to the patient.
- a microprocessor uses a lookup table to determine how many microprocessors to fire when providing the shocking pulse.
- This lookup table is preferably as follows:
- the defibrillator can vary the voltage of the shocking pulse according to the measured impedance of the patient, so as to ensure that an adequate voltage and amperage is applied to the patient, without applying too much current to the patient; and the defibrillator always provides at least 200 ⁇ F of capacitance, so as to ensure that the advantages of a 200 ⁇ F pulse profile is obtained.
- the present invention also provides a capacitance which varies in inverse proportion to the measured patient impedance, i.e., the defibrillator provides high capacitance for low patient impedance, and less capacitance for high patient impedance.
- the voltage and effective capacitance being applied to the patient can be regulated by selectively inserting (e.g., by appropriate switching) resistors into the waveform circuit.
- the defibrillator is configured to (1) take energy out of one or more batteries; (2) store that energy into some number of capacitors; (3) pre-pulse the patient, using at least one of the capacitors, so as to test the thoracic impedance of the patient; (4) after determining the specific impedance of the patient, calculate the voltage to be applied to the patient; and (5) fire the appropriate number of capacitors to provide the desired shock pulse.
- the defibrillator' s capacitance is provided by a fixed charge voltage, and the waveform's current is controlled by capacitance.
- Fig. 14 is a schematic illustration of the bi-phasic waveform produced by defibrillator system 35.
- Defibrillator 40 is compact, rugged, inexpensive, easy to use, water-resistant and electronically efficient. Defibrillator 40 is lightweight, weighing less than 6 pounds, and preferably weighing less than 3 pounds. Defibrillator 40 has an expected field life of 5 years.
- defibrillator 40 is in the form of a unit (or box) comprising a body 50 and a lid 55.
- Body 50 which may be partially or completely coated with rubber and/or rubber-like materials, houses the electronics associated with the defibrillator.
- Lid 55 provides a cover for the top of body 50 and houses an electrode package 60 (Fig. 4) containing electrodes 45 (Fig. 2), as will hereinafter be discussed in further detail.
- Body 50 houses the electronic hardware and software associated with the defibrillator.
- Body 50 comprises a front casing 65 (Fig. 16) and a back cover 70. In general, the configuration of body 50 is specifically designed to provide high voltage separation.
- front casing 65 comprises the following components: 1. Battery Slot 75 and Battery 80: Body 50 includes a battery slot 75 (Figs. 17 and 18) which receives a battery 80 (Figs. 17 and 19), such as a Lithium Manganese Dioxide battery.
- battery 80 includes a peripheral gasket 85 (Fig. 19) so that a substantially watertight seal will be formed when battery 80 is inserted in battery slot 75.
- the bottom of battery 80 makes a male-female engagement with the floor of battery slot 75 so as to ensure reliable engagement of battery contacts 86 (Fig.
- Connector Slot 90 The pair of electrodes 45 (Fig. 2) that are to be used in conjunction with defibrillator 40 are linked to body 50 via a connector (see below) that plugs into a connector slot 90 (Fig. 17) .
- the electrodes are preferably connected to body
- Power Button 95 Unlike many prior art defibrillators that power up upon opening, defibrillator 40 is not automatically turned on when opened by the user. Instead, there is a power button 95 (Fig. 17) that needs to be pushed for the defibrillator unit to be activated.
- Test Status Indicator 100 Defibrillator 40 is equipped with a fault analysis system that helps detect malfunctions associated with the unit. In the instance of a detected malfunction, the unit has a visual indicator or a test status indicator (e.g., an LED) 100 (Fig. 17) that can be observed by the user (e.g., an EMT, hospital nurse, etc.), thereby informing the user that the unit is malfunctional and needs to be replaced.
- a test status indicator e.g., an LED
- Fig. 17 a test status indicator that can be observed by the user (e.g., an EMT, hospital nurse, etc.), thereby informing the user that the unit is malfunctional and needs to be replaced.
- Voice System When the defibrillator is turned on, a voice prompt that can be heard over speaker 105 (Fig. 20) accessed through speaker ports 110 (Fig. 21) guides the user through the American Heart Association ® (AHA) ABCD sequence of evaluating the patient's condition. If it appears that defibrillation is required, the electrodes 45 are available for placement on the victim.
- the defibrillation method of the present invention involves a two-step process of applying the electrodes and pressing a single button (shock button 160, discussed below) for resuscitation.
- Speaker 105 also allows the user to be provided with instructions from a remote source (e.g., a hospital) over a radio link.
- a microphone 115 (Fig. 20) accessed through microphone ports 120 (Fig.
- a hydrophobic membrane (not shown) be placed between speaker 105 and speaker ports 110, between microphone 115 and microphone ports 120, and between alarm 130 and alarm ports 132.
- a hydrophobic membrane may comprise Pallflex TL-1741 membrane material.
- speaker 105, microphone 115 and/or alarm 130 are all mounted directly to a circuit board, one or more gaskets 133 (Fig. 20) are positioned about the elements, and then one or more hydrophobic membranes are placed between the gaskets and the ports, whereby to provide a substantially water-resistant unit.
- LCD Display 135 The unit comprises a liquid crystal display (LCD) 135 (Fig. 17) that displays pertinent information such as electrocardiogram (ECG) graphs and also helps guide the user.
- LCD display of the preferred embodiment is a 4-line display, but it is not intended to be limited thereto.
- Scroll buttons 140 are provided to facilitate presentation of text and/or graphics on LCD display 135.
- a universal alert comprising, for example, an LED
- Fig. 17 can be activated (e.g., lit) so as to advise the user to consult the user manual which accompanies the system.
- Flashcard Slot 150 In a preferred form of the invention, defibrillator 40 further comprises a data recording capability which records data (such as ECG data related to various cardiac parameters) related to every defibrillation event. Flashcard slot 150 (Fig. 18) is preferably used for transferring this stored data to a flash memory card. Preferably flashcard slot 150 is protected from electrostatic discharge (ESD) with an insulating membrane, e.g., a 0.005 polycarbonate sheet 152 (Fig. 18) . The configuration of the battery and battery well also helps protect flashcard slot 150 from ESD. Preferably the PC board 153 (Fig.
- a flash memory card located in flashcard slot 150 may also be retrieved by the system to configure device operating parameters and manual defibrillation control button operation.
- an infrared (IR) port 155 (Fig. 17) may also be used to transfer information out of, or into, the defibrillator.
- IR port 155 can be used to collect fault analysis data from the defibrillator, e.g., a group of defibrillators 35 stored for use (e.g., in an ambulance or in an airliner) may be quickly and easily queried as to their fault status using their IR ports 155.
- Shock Button 160 When electrodes 45 have been applied to the patient and the defibrillator' s internal electronics determine that the patient is in need of cardiac defibrillation, the defibrillator prompts the user to depress shock button 160 (Fig. 17) so as to generate an electro-therapeutic pulse to stop fibrillation and restore the normal heart rhythm. Alternatively, in another embodiment, a medically trained individual could use shock button 160 to manually generate the defibrillating electric pulse.
- Defibrillator Electronics 165 Defibrillator 40 comprises internal electronics 165 (Fig. 20) that preferably use the aforementioned stacked, switched capacitor design to generate an electric pulse having the desired bi-phasic waveform. The use of mechanical relays is preferably avoided.
- the defibrillator is preferably configured to deliver a maximum of 10 defibrillation shocks with a single primary cell battery.
- Defibrillator 40 is preferably a 200/360 J (joule) biphasic escalating energy defibrillator which provides the best clinically effective defibrillation therapy.
- the internal electronics 165 of defibrillator 40 are preferably adapted to generate a bi-phasic waveform of escalating energy, with 200 J being delivered on the first shock and 360 J being delivered on subsequent shocks.
- the defibrillator is specifically designed to limit peak current in low impedance patients so as to avoid injury.
- defibrillator electronics 165 residing on one or more PC boards, preferably comprise a plurality of capacitors configured in a stacked, switchable configuration.
- the system is designed to (i) charge its capacitors to a fixed charge voltage, (ii) generate a very brief pre-pulse, using the energy stored in one pair of stacked capacitors, (iii) measure the impedance of the patient using the pre-pulse, and (iv) apply an appropriate bi-phasic waveform to the patient so as to defibrillate.
- the electric pulse will be brief enough, and generate a low enough amperage, to avoid harming the patient with excess current.
- the application of the pre-pulse to the patient will allow the impedance of the patient to be measured using exactly the same type of current which will be applied to the patient during defibrillation, thus allowing for more accurate impedance measurements.
- the stacked capacitors will be left substantially fully charged for the subsequent defibrillating shock; thus, the pre-pulse will enable a very accurate measurement of impedance without delaying application of the defibrillation shock.
- defibrillator 40 is insulated and is radiation shielded, including radio frequency (RF) shielded.
- the defibrillator is preferably constructed so as to be resistant to a wide range of damped sine wave or bi-phasic external defibrillation shocks which may be applied to a patient while the defibrillator of the present invention is also connected to the same patient.
- the defibrillator is also constructed to be shock resistant, e.g., the circuit boards are rigidly mounted to front casing 65 so as to guard against mechanical shocks and vibrations.
- Electrodes 45 As discussed above, the defibrillator' s lid 55
- electrode package 60 preferably comprises a tray 170 and a peel-off top 175. Tray 170 and peel-off top 175 together form a substantially water-tight enclosure for housing the pair of electrodes 45, their respective leads 180 and a connector 185 which is used to connect electrode leads 180 to the defibrillator' s connector slot 90 (Fig. 17) .
- connector 185 include resistors which can be used to uniquely identify the associated electrodes, e.g., a resistor of one value could identify an adult electrode, a resistor of another value could identify a pediatric electrode, etc.
- tray 170 is a semi-rigid structure configured to make a snap-fit with the defibrillator' s lid 55 (Fig. 16), so that electrode package 60 can be releasably secured to the defibrillator. More particularly, and looking now at Figs. 27-29, tray 170 has a peripheral lip 190 (Fig. 27) , a pair of feet 195 (Fig. 29), a pair of feet 197 (Fig. 28) and a latch 200 (Fig. 27) .
- defibrillator lid 55 has a pair of tabs 205 (Fig. 30), a pair of feet 210 (Fig. 31) and a latch 215 (Fig.
- Tray feet 195 (Fig. 29) engage lid tabs 205 (Fig. 30), tray feet 197 (Fig. 27) engage lid feet 210 (Fig. 31), and tray latch 200 (Fig. 27) engages lid latch 215 (Fig. 31), whereby electrode package 60 may be releasably secured to the underside of lid 55 prior to use.
- tray 170 is formed out of Ticona Topas 8007 material and peel-off top 175 is formed out of 48 gauge polyester/10.8# white LDPE 0.001 foil/3 mil coextrusion peel seal blend.
- electrodes 45 are preferably manufactured as follows:
- An assembly release liner 220 is placed on a work surface (Fig. 32) .
- a hydrogel pad 225 is placed on assembly release liner 220 (Fig. 33) .
- a foam ring 230 is placed around hydrogel pad 225 (Fig. 33) .
- a double sticky tape 235 having a release liner 240 on one side thereof, is laid over a portion of hydrogel pad 225 and foam ring 230 (Fig. 34).
- a conductor subassembly 245 is mounted to hydrogel pad 225 and foam ring 230. More particularly, conductor subassembly 245 is first formed by fastening a conductor lead 180 to a conductor 255 via a socket
- subassembly 245 is mounted to hydrogel pad 225 and foam ring 230 by laying an insulator label 270 against foam ring 230 (Fig. 36), and then placing subassembly 245 against hydrogel pad 225 and foam ring 230, with socket 260 and ring 265 lying against insulator label 270.
- isolating double sticky tape 235 between socket 260 and the hydrogel pad 225 current is prevented from passing from socket 260 directly into the body; instead, the current is distributed throughout the substantial surface area of the complete conductor 255, whereby to enhance even electrical transmission to the patient.
- the presence of the insulating double sticky tape under the conductor neck 272 (Fig. 36) further promotes current distribution prior to entering the patient.
- the four rounded corners 273 (Fig. 36) of conductor 255 minimize current concentrations which can result in hot spots.
- conductor 255 is preferably placed against hydrogel pad 225 so as to form a slightly larger border 274 (Fig. 36) at the far end of the conductor so as to enhance current distribution at the far end of the conductor.
- a foam backing 275 is placed against foam ring 230, hydrogel pad 225 and conductor 255 (Fig. 37) .
- Insulator label 270 is folded over ring 265 (Fig. 38) . This completes assembly of one electrode.
- the electrode is then lifted off assembly release liner 220 and placed against a release liner 280 (Fig. 38) .
- steps 1-8 are then repeated so as to form a second electrode.
- the second electrode is mounted to the opposite side of the same release liner 280.
- release liner 280 is placed inside tray 170 and the tray is sealed with peel-off top 175 so as to form the complete electrode package 60.
- release liner 280 is mounted to a plurality of posts 285 formed on tray 170, whereby the electrodes 45 will be quickly and easily presented to the user upon opening electrode package 60.
- electrode 45 provide an unusually effective mechanism for administering the desired electrical pulse to the patient: less tenting is found to occur during muscle contraction, which in turn results in less arcing, which can cause burning and loss of energy.
- the use of a more aggressive skin adhesive can also contribute to this effect.
- the electrodes are placed inside a relatively rigid tray, a sheet of sealing material is used to seal the area of the tray, thereby encapsulating or sealing the electrodes within the tray, and then the entire assembly is snapped into a releasable mount on the underside of the defibrillator' s lid.
- the lid is opened, the sheet of sealing material is pulled away to expose the electrodes, and then the electrodes are applied to the patient.
- the operator is able to remove the tray from the underside of the lid and dispose of it along with the used electrodes, and is able to replace the used tray with a new tray containing sealed electrodes.
- the electrodes are held on opposite sides of the release liner which is mounted to the tray; opening the tray causes the two electrodes to be conveniently presented to the user, thereby facilitating handling of the electrodes and reducing the time it takes to apply the electrodes to the patient. This results in earlier first shock delivery to the patient, thus increasing their chance for survival.
- Defibrillator system 35 is generally used as follows .
- a first-responder e.g., a flight attendant
- the first-responder i.e., the user
- the lid 55 Fig. 16
- power button 95 Fig. 17
- Defibrillator electronics 165 Figs. 20 and 23
- speaker 105 Fig. 20
- Speaker 105 also allows the user to receive instructions from a remote site (e.g., a hospital) via radio link.
- the user will open the electrode package's peel-off top 175 (Fig. 26) , with or without removing the electrode package from lid 55, and then connect electrode connector 185 (Fig. 26) to the defibrillator' s connector slot 90 (Fig. 17), if the electrode connector 185 is not already pre-connected to the defibrillator' s connector slot 90.
- the elastic nature of release liner 280 (Fig. 39) will cause the release liner to present the electrodes out of the recess of tray 170.
- the user then peels electrodes 45 off to release liner 280 and applies them to the chest of the patient.
- the defibrillator' s electronics 165 (Figs.
- Electrodes 45 then use electrodes 45 to monitor the victim's heart to determine of defibrillation is required. If electronics 165 determine that defibrillation is required, speaker 105 will prompt the user to depress shock button 160 (Fig. 17). When the shock button is depressed, electronics 165 cause a low voltage, low current pre-pulse (Fig. 14) to be very briefly applied to the patient, whereby the patient's thoracic impedance may be measured by electronics 165. Based on this measured impedance, electronics 165 then cause a bi-phasic shock pulse of proper peak current, tilt and duration to be applied to the patient so as to effect defibrillation. While the foregoing is occurring, microphone 115 (Fig. 20) allows sounds at the emergency site to be recorded by the unit or transmitted to a remote site (e.g., a hospital) via a radio link.
- a remote site e.g., a hospital
- the present invention provides for a compact, rugged, lightweight, inexpensive, easy to use, water-resistant, and electronically efficient defibrillator that preferably uses stacked, switchable capacitors to generate a desired biphasic waveform for cardiac resuscitation.
- the compact defibrillator of the present invention can be broadly deployed in hospitals (or in any cardiac emergency situation) so as to provide for rapid coverage of unexpected patient events, and a greater compliance with Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and other regulatory standards.
- JCAHO Joint Commission on Accreditation of Healthcare Organizations
- defibrillator system 35 has been described as being an automated external defibrillator (AED) system, it could also be implemented as a non-automatic external defibrillator system.
- defibrillator system 35 has been described as comprising electrodes of the sort comprising hydrogel pads, it could also be used in conjunction with defibrillator paddles.
- the present invention should not be limited by the mechanism via which the tray containing the electrodes is attached to the lid, and the mechanism via which the lid is attached to the body of the defibrillator unit.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002459049A CA2459049A1 (en) | 2001-08-31 | 2002-08-30 | Automated external defibrillator (aed) system |
EP02759518A EP1432474A4 (en) | 2001-08-31 | 2002-08-30 | Automated external defibrillator (aed) system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31603401P | 2001-08-31 | 2001-08-31 | |
US60/316,034 | 2001-08-31 | ||
US37946702P | 2002-05-10 | 2002-05-10 | |
US60/379,467 | 2002-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003020362A2 true WO2003020362A2 (en) | 2003-03-13 |
WO2003020362A3 WO2003020362A3 (en) | 2004-03-18 |
Family
ID=26980199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/027817 WO2003020362A2 (en) | 2001-08-31 | 2002-08-30 | Automated external defibrillator (aed) system |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030167075A1 (en) |
EP (1) | EP1432474A4 (en) |
CA (1) | CA2459049A1 (en) |
WO (1) | WO2003020362A2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10251344A1 (en) * | 2002-11-05 | 2004-05-19 | Metrax Gmbh | Defibrillator has electrodes accommodated in chamber formed on inside of hinged or removable cover and connected to electronics via cable, plug/socket when defibrillator not in use |
WO2005030327A1 (en) * | 2003-09-30 | 2005-04-07 | Koninklijke Philips Electronics, N.V. | Identification system for defibrillator electrode package |
WO2008058735A1 (en) * | 2006-11-15 | 2008-05-22 | Heartsine Technologies Limited | Single-use external defibrillator |
US8615295B2 (en) | 2009-03-17 | 2013-12-24 | Cardiothrive, Inc. | External defibrillator |
US8781576B2 (en) | 2009-03-17 | 2014-07-15 | Cardiothrive, Inc. | Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current |
WO2014155367A1 (en) * | 2013-03-29 | 2014-10-02 | Koninklijke Philips N.V. | Prevention of inadvertent battery depletion ii an automatic external defibrillator |
US9616243B2 (en) | 2013-06-14 | 2017-04-11 | Cardiothrive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US9656094B2 (en) | 2013-06-14 | 2017-05-23 | Cardiothrive, Inc. | Biphasic or multiphasic pulse generator and method |
US9833630B2 (en) | 2013-06-14 | 2017-12-05 | Cardiothrive, Inc. | Biphasic or multiphasic pulse waveform and method |
US9907970B2 (en) | 2013-06-14 | 2018-03-06 | Cardiothrive, Inc. | Therapeutic system and method using biphasic or multiphasic pulse waveform |
US10149973B2 (en) | 2013-06-14 | 2018-12-11 | Cardiothrive, Inc. | Multipart non-uniform patient contact interface and method of use |
US10279189B2 (en) | 2013-06-14 | 2019-05-07 | Cardiothrive, Inc. | Wearable multiphasic cardioverter defibrillator system and method |
US10828500B2 (en) | 2017-12-22 | 2020-11-10 | Cardiothrive, Inc. | External defibrillator |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006058164A2 (en) * | 2004-11-24 | 2006-06-01 | Access Cardiosystems, Inc. | Automated external defibrillator (aed) with discrete sensing pulse for use in configuring a therapeutic biphasic waveform |
US7457662B2 (en) * | 2005-09-09 | 2008-11-25 | Cardiac Science Corporation | Method and apparatus for variable capacitance defibrillation |
US20070057780A1 (en) * | 2005-09-13 | 2007-03-15 | Martha Bridges | Apparatus for alerting a driver preparing to exit a motor vehicle and method thereof |
WO2007081609A2 (en) * | 2005-11-18 | 2007-07-19 | Scientific Pathways International, Llc | Cpr analysis system and method |
US8594771B2 (en) * | 2005-12-28 | 2013-11-26 | General Electric Company | Devices and methods for self-administered ECG examinations |
US8010190B2 (en) | 2006-05-26 | 2011-08-30 | Cardiac Science Corporation | CPR feedback method and apparatus |
US7714737B1 (en) | 2006-08-17 | 2010-05-11 | James Morningstar | Warning system for child left unattended in vehicle |
CN105999553A (en) * | 2006-10-27 | 2016-10-12 | 赛昂国际医疗控股有限公司 | Automatic external defibrillator (AED) capable of wireless monitoring of multiple patients |
CN101873844A (en) * | 2007-06-01 | 2010-10-27 | 心脏科学有限公司 | System, method, and apparatus for assisting a rescuer in resuscitation |
US20090005827A1 (en) * | 2007-06-26 | 2009-01-01 | David Weintraub | Wearable defibrillator |
US20090270930A1 (en) * | 2008-04-25 | 2009-10-29 | Physio-Control, Inc. | External Defibrillator With Adaptive Protocols |
EP2637738A1 (en) * | 2010-11-11 | 2013-09-18 | Koninklijke Philips Electronics N.V. | Carrying case with improved access for defibrillator and accessories |
JP5903105B2 (en) * | 2010-11-11 | 2016-04-13 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Defibrillator carrying case with improved latch |
EP2637742B1 (en) * | 2010-11-11 | 2016-09-14 | Koninklijke Philips N.V. | Carrying case handle for defibrillator and accessories |
JP5938414B2 (en) * | 2010-11-11 | 2016-06-22 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Carrying case for accessories including defibrillator and CPR meter bracket |
WO2012063218A2 (en) * | 2010-11-11 | 2012-05-18 | Koninklijke Philips Electronics N.V. | Carrying case for defibrillator and accessories |
JP5919293B2 (en) * | 2010-11-11 | 2016-05-18 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Defibrillator carrying case with integrated button tester |
WO2013128308A1 (en) * | 2012-02-28 | 2013-09-06 | Koninklijke Philips N.V. | Single use aed |
US9393402B2 (en) * | 2013-08-12 | 2016-07-19 | Physio-Control, Inc. | Electrode tray with integrated connector and storage for wires |
US9289590B2 (en) | 2013-08-12 | 2016-03-22 | Physio-Control, Inc. | Peelable lid for container with multi-point peel system |
ES2828361T3 (en) | 2014-02-24 | 2021-05-26 | Element Science Inc | External defibrillator |
USD759249S1 (en) | 2014-10-30 | 2016-06-14 | The American National Red Cross | Electronic device |
US20160375261A1 (en) * | 2015-06-25 | 2016-12-29 | Physio-Control, Inc. | Event-Driven Transmission of Treatment Data |
WO2017035502A1 (en) | 2015-08-26 | 2017-03-02 | Element Science, Inc. | Wearable devices |
US10946207B2 (en) | 2017-05-27 | 2021-03-16 | West Affum Holdings Corp. | Defibrillation waveforms for a wearable cardiac defibrillator |
EP3863511A4 (en) | 2018-10-10 | 2022-04-06 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
USD926323S1 (en) | 2020-03-30 | 2021-07-27 | Zoll Medical Corporation | Automated external defibrillator electrode pad |
EP4240478B1 (en) | 2021-01-28 | 2024-01-03 | Usa Medical Electronix, Inc. | Pocket-sized automated external defibrillator |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291699A (en) * | 1978-09-21 | 1981-09-29 | Purdue Research Foundation | Method of and apparatus for automatically detecting and treating ventricular fibrillation |
US4785812A (en) * | 1986-11-26 | 1988-11-22 | First Medical Devices Corporation | Protection system for preventing defibrillation with incorrect or improperly connected electrodes |
US5441520A (en) * | 1993-04-06 | 1995-08-15 | Hewlett-Packard Corporation | Defibrillator patient connection system with automatic identification |
US5466244A (en) * | 1993-05-18 | 1995-11-14 | Heartstream, Inc. | Defibrillator electrode system |
US5658316A (en) * | 1995-07-03 | 1997-08-19 | Automatic Defibrillator, Inc. | Portable defibrillator with disposable power pack |
US5674249A (en) * | 1996-05-02 | 1997-10-07 | Incontrol, Inc. | Atrial defibrillation system having a portable communication device |
US5674251A (en) * | 1994-04-21 | 1997-10-07 | Medtronic, Inc. | Method and apparatus for treatment of atrial fibrillation |
US5697955A (en) * | 1996-05-10 | 1997-12-16 | Survivalink Corporation | Defibrillator electrodes and date code detector circuit |
US5800463A (en) * | 1996-12-18 | 1998-09-01 | Zmd Corporation | Electrotherapy circuit having controlled peak current |
US5916244A (en) * | 1998-02-20 | 1999-06-29 | Katecho, Inc. | External heart stimulation electrode having reduced edge effect |
US6038464A (en) * | 1998-02-09 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US6041254A (en) * | 1997-03-05 | 2000-03-21 | Physio-Control Manufacturing Corporation | H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator and further including a protective component that has both inductive and resistive properties |
US6097987A (en) * | 1998-12-30 | 2000-08-01 | Medical Research Laboratories, Inc. | External defibrillator electrode apparatus |
US6108578A (en) * | 1998-09-02 | 2000-08-22 | Heartstream, Inc. | Configurable arrhythmia analysis algorithm |
US6223088B1 (en) * | 1998-11-09 | 2001-04-24 | Katecho, Incorporated | Electrode and connector assembly and method for using same |
US6263238B1 (en) * | 1998-04-16 | 2001-07-17 | Survivalink Corporation | Automatic external defibrillator having a ventricular fibrillation detector |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3093136A (en) * | 1960-05-25 | 1963-06-11 | Mine Safety Appliances Co | Ventricular defibrillator |
US3782389A (en) * | 1972-01-20 | 1974-01-01 | Health Technology Labs Inc | Computer controlled defibrillator |
US3886950A (en) * | 1973-10-01 | 1975-06-03 | Spacelabs Inc | Defibrillator |
US3860009A (en) * | 1973-11-29 | 1975-01-14 | David Bell | Computer controlled defibrillator |
GB1481469A (en) * | 1974-10-28 | 1977-07-27 | Anderson J | Defibrillator |
US4077413A (en) * | 1976-05-04 | 1978-03-07 | The Burdick Corporation | Defibrillator |
US4090519A (en) * | 1976-05-10 | 1978-05-23 | James Francis Pantridge | Defibrillators |
US4574810A (en) * | 1984-10-05 | 1986-03-11 | Lerman Bruce B | Automatic threshold defibrillator |
US4823796A (en) * | 1987-04-03 | 1989-04-25 | Laerdal Manufacturing Corp. | Defibrillator circuit for producing a trapezoidal defibrillation pulse |
US5222480A (en) * | 1988-12-30 | 1993-06-29 | Physio-Control Corporation | Defibrillator discharge calibration system |
US5507781A (en) * | 1991-05-23 | 1996-04-16 | Angeion Corporation | Implantable defibrillator system with capacitor switching circuitry |
US5230336A (en) * | 1991-08-16 | 1993-07-27 | Ventritex, Inc. | Method and apparatus for impedance based automatic pulse duration adjustment for defibrillation shock delivery |
EP0553864B1 (en) * | 1992-01-30 | 1999-10-27 | Cardiac Pacemakers, Inc. | Defibrillator waveform generator for generating waveform of long duration |
US5534015A (en) * | 1992-02-18 | 1996-07-09 | Angeion Corporation | Method and apparatus for generating biphasic waveforms in an implantable defibrillator |
US5306291A (en) * | 1992-02-26 | 1994-04-26 | Angeion Corporation | Optimal energy steering for an implantable defibrillator |
US5607454A (en) * | 1993-08-06 | 1997-03-04 | Heartstream, Inc. | Electrotherapy method and apparatus |
US5769872A (en) * | 1996-12-18 | 1998-06-23 | Zmd Corporation | Electrotherapy circuit and method for shaping current waveforms |
WO1998044990A1 (en) * | 1997-04-08 | 1998-10-15 | Survivlink Corporation | Aami specification optimized truncated exponential waveform |
US5999852A (en) * | 1997-04-18 | 1999-12-07 | Physio-Control Manufacturing Corporation | Defibrillator method and apparatus |
US6241751B1 (en) * | 1999-04-22 | 2001-06-05 | Agilent Technologies, Inc. | Defibrillator with impedance-compensated energy delivery |
-
2002
- 2002-08-30 WO PCT/US2002/027817 patent/WO2003020362A2/en not_active Application Discontinuation
- 2002-08-30 CA CA002459049A patent/CA2459049A1/en not_active Abandoned
- 2002-08-30 EP EP02759518A patent/EP1432474A4/en not_active Withdrawn
- 2002-08-30 US US10/232,645 patent/US20030167075A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291699A (en) * | 1978-09-21 | 1981-09-29 | Purdue Research Foundation | Method of and apparatus for automatically detecting and treating ventricular fibrillation |
US4785812A (en) * | 1986-11-26 | 1988-11-22 | First Medical Devices Corporation | Protection system for preventing defibrillation with incorrect or improperly connected electrodes |
US5441520A (en) * | 1993-04-06 | 1995-08-15 | Hewlett-Packard Corporation | Defibrillator patient connection system with automatic identification |
US5466244A (en) * | 1993-05-18 | 1995-11-14 | Heartstream, Inc. | Defibrillator electrode system |
US5674251A (en) * | 1994-04-21 | 1997-10-07 | Medtronic, Inc. | Method and apparatus for treatment of atrial fibrillation |
US5658316A (en) * | 1995-07-03 | 1997-08-19 | Automatic Defibrillator, Inc. | Portable defibrillator with disposable power pack |
US5674249A (en) * | 1996-05-02 | 1997-10-07 | Incontrol, Inc. | Atrial defibrillation system having a portable communication device |
US5697955A (en) * | 1996-05-10 | 1997-12-16 | Survivalink Corporation | Defibrillator electrodes and date code detector circuit |
US5800463A (en) * | 1996-12-18 | 1998-09-01 | Zmd Corporation | Electrotherapy circuit having controlled peak current |
US6041254A (en) * | 1997-03-05 | 2000-03-21 | Physio-Control Manufacturing Corporation | H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator and further including a protective component that has both inductive and resistive properties |
US6038464A (en) * | 1998-02-09 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US5916244A (en) * | 1998-02-20 | 1999-06-29 | Katecho, Inc. | External heart stimulation electrode having reduced edge effect |
US6263238B1 (en) * | 1998-04-16 | 2001-07-17 | Survivalink Corporation | Automatic external defibrillator having a ventricular fibrillation detector |
US6108578A (en) * | 1998-09-02 | 2000-08-22 | Heartstream, Inc. | Configurable arrhythmia analysis algorithm |
US6223088B1 (en) * | 1998-11-09 | 2001-04-24 | Katecho, Incorporated | Electrode and connector assembly and method for using same |
US6097987A (en) * | 1998-12-30 | 2000-08-01 | Medical Research Laboratories, Inc. | External defibrillator electrode apparatus |
Non-Patent Citations (1)
Title |
---|
See also references of EP1432474A2 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10251344A1 (en) * | 2002-11-05 | 2004-05-19 | Metrax Gmbh | Defibrillator has electrodes accommodated in chamber formed on inside of hinged or removable cover and connected to electronics via cable, plug/socket when defibrillator not in use |
DE10251344B4 (en) * | 2002-11-05 | 2006-07-13 | Metrax Gmbh | defibrillator |
WO2005030327A1 (en) * | 2003-09-30 | 2005-04-07 | Koninklijke Philips Electronics, N.V. | Identification system for defibrillator electrode package |
US7689278B2 (en) | 2003-09-30 | 2010-03-30 | Koninklijke Philips Electronics, N.V. | Identification system for defibrillator electrode package |
WO2008058735A1 (en) * | 2006-11-15 | 2008-05-22 | Heartsine Technologies Limited | Single-use external defibrillator |
US8781576B2 (en) | 2009-03-17 | 2014-07-15 | Cardiothrive, Inc. | Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current |
US9101778B2 (en) | 2009-03-17 | 2015-08-11 | Cardiothrive, Inc. | Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current |
US11311716B2 (en) | 2009-03-17 | 2022-04-26 | Cardiothrive, Inc. | External defibrillator |
US8615295B2 (en) | 2009-03-17 | 2013-12-24 | Cardiothrive, Inc. | External defibrillator |
RU2677533C2 (en) * | 2013-03-29 | 2019-01-17 | Конинклейке Филипс Н.В. | Prevention of inadvertent depletion of lithium battery of automatic external defibrillator |
WO2014155367A1 (en) * | 2013-03-29 | 2014-10-02 | Koninklijke Philips N.V. | Prevention of inadvertent battery depletion ii an automatic external defibrillator |
CN105188842A (en) * | 2013-03-29 | 2015-12-23 | 皇家飞利浦有限公司 | Prevention of inadvertent battery depletion ii an automatic external defibrillator |
US10238881B2 (en) | 2013-03-29 | 2019-03-26 | Koninklijke Philips N.V. | Prevention of inadvertent battery depletion in an automatic external defibrillator |
US9833630B2 (en) | 2013-06-14 | 2017-12-05 | Cardiothrive, Inc. | Biphasic or multiphasic pulse waveform and method |
US9907970B2 (en) | 2013-06-14 | 2018-03-06 | Cardiothrive, Inc. | Therapeutic system and method using biphasic or multiphasic pulse waveform |
US10149973B2 (en) | 2013-06-14 | 2018-12-11 | Cardiothrive, Inc. | Multipart non-uniform patient contact interface and method of use |
US9855440B2 (en) | 2013-06-14 | 2018-01-02 | Cardiothrive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US9656094B2 (en) | 2013-06-14 | 2017-05-23 | Cardiothrive, Inc. | Biphasic or multiphasic pulse generator and method |
US10279189B2 (en) | 2013-06-14 | 2019-05-07 | Cardiothrive, Inc. | Wearable multiphasic cardioverter defibrillator system and method |
US10773090B2 (en) | 2013-06-14 | 2020-09-15 | CardioThive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US10870012B2 (en) | 2013-06-14 | 2020-12-22 | Cardiothrive, Inc. | Biphasic or multiphasic pulse waveform and method |
US11083904B2 (en) | 2013-06-14 | 2021-08-10 | Cardiothrive, Inc. | Bisphasic or multiphasic pulse waveform and method |
US11147962B2 (en) | 2013-06-14 | 2021-10-19 | Cardiothrive, Inc. | Multipart non-uniform patient contact interface and method of use |
US9616243B2 (en) | 2013-06-14 | 2017-04-11 | Cardiothrive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US11712575B2 (en) | 2013-06-14 | 2023-08-01 | Cardiothrive, Inc. | Wearable multiphasic cardioverter defibrillator system and method |
US10828500B2 (en) | 2017-12-22 | 2020-11-10 | Cardiothrive, Inc. | External defibrillator |
Also Published As
Publication number | Publication date |
---|---|
EP1432474A4 (en) | 2008-05-28 |
EP1432474A2 (en) | 2004-06-30 |
WO2003020362A3 (en) | 2004-03-18 |
CA2459049A1 (en) | 2003-03-13 |
US20030167075A1 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030167075A1 (en) | Automated external defibrillator (AED) system | |
EP0756878B1 (en) | Automated external defribillator | |
US10657796B2 (en) | Method and system for expediting the rescue of victims experiencing sudden cardiac arrest (SCA) when used in conjunction with an automated external defibrillator (AED) | |
US5919212A (en) | Watchdog timer for automated external defibrillator | |
US6134479A (en) | Electrode triad for external defibrillation | |
US6125298A (en) | Defibrillation system for pediatric patients | |
EP0997162B2 (en) | Electrotherapy apparatus | |
JP5593293B2 (en) | OTC automatic external defibrillator with quick-attach battery | |
US20080177341A1 (en) | Automated external defibrillator (AED) system with multiple patient wireless monitoring capability for use in mass casualty incidents | |
US6405082B1 (en) | Method and apparatus for distinguishing between therapy modes in a defibrillator | |
US20190168009A1 (en) | Medical device with lack-of-readiness alarm | |
JP2005522284A (en) | Defibrillation system and method designed for quick installation | |
US20060111750A1 (en) | Automated external defibrillator (AED) with discrete sensing pulse for use in configuring a therapeutic biphasic waveform | |
WO2013128327A1 (en) | Aed with preconnected electrodes | |
US20030055459A1 (en) | Method and apparatus for defibrillating patients of all ages | |
WO2005009537A1 (en) | Portable defibrillator with bypass line power emergency charching of capacitor | |
WO2015167606A1 (en) | Portable cardiac defibrillators with subcutaneous electrodes and associated systems and methods | |
EP0757912B1 (en) | Automated external defibrillator with self-test system | |
AU2002324850A1 (en) | Automated external defibrillator (AED) system | |
Sanyaolu | External Defibrillator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2459049 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002759518 Country of ref document: EP Ref document number: 2002324850 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2002759518 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |